- Home
- BMBL vs BBOT Comparison
BMBL vs BBOT Comparison
Compare BMBL & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMBL | BBOT |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.4M | 442.6M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | BMBL | BBOT |
|---|---|---|
| Price | $5.97 | $2.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 12 |
| Target Price | $4.05 | ★ $24.55 |
| AVG Volume (30 Days) | ★ 7.7M | 557.4K |
| Earning Date | 11-09-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 99.93 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $965,658,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.44 | $2.93 |
| 52 Week High | $5.98 | $14.87 |
Technical Indicators
Market Signals| Indicator | BMBL | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 90.54 | 14.23 |
| Support Level | $2.69 | N/A |
| Resistance Level | N/A | $9.36 |
| Average True Range (ATR) | 0.18 | 0.21 |
| MACD | 0.36 | 0.06 |
| Stochastic Oscillator | 99.58 | 1.18 |
Price Performance
Historical ComparisonAbout BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company operates as one operating segment with revenue derived in the form of recurring subscriptions and in-app purchases. The company operates in USA, which derives maximum revenue; and Rest of the World.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.